272 related articles for article (PubMed ID: 27875549)
1. The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.
Chiu WC; Lee YC; Su YH; Wang YY; Tsai CH; Hou YA; Wang CH; Huang YF; Huang CJ; Chou SH; Hsieh PW; Yuan SF
PLoS One; 2016; 11(11):e0166453. PubMed ID: 27875549
[TBL] [Abstract][Full Text] [Related]
2. The synthetic β-nitrostyrene derivative CYT-Rx20 induces breast cancer cell death and autophagy via ROS-mediated MEK/ERK pathway.
Hung AC; Tsai CH; Hou MF; Chang WL; Wang CH; Lee YC; Ko A; Hu SC; Chang FR; Hsieh PW; Yuan SS
Cancer Lett; 2016 Feb; 371(2):251-61. PubMed ID: 26683774
[TBL] [Abstract][Full Text] [Related]
3. CYT-Rx20 Inhibits Cervical Cancer Cell Growth and Migration Through Oxidative Stress-Induced DNA Damage, Cell Apoptosis, and Epithelial-to-Mesenchymal Transition Inhibition.
Wang YY; Hsieh PW; Chen YK; Hu SC; Hsu YL; Tsai CH; Yuan SF
Int J Gynecol Cancer; 2017 Sep; 27(7):1306-1317. PubMed ID: 30814237
[TBL] [Abstract][Full Text] [Related]
4. CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis.
Wang YY; Chen YK; Hu SC; Hsu YL; Tsai CH; Chi TC; Huang WL; Hsieh PW; Yuan SF
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1129-1140. PubMed ID: 28500555
[TBL] [Abstract][Full Text] [Related]
5. Synthetic β-nitrostyrene derivative CYT-Rx20 as inhibitor of oral cancer cell proliferation and tumor growth through glutathione suppression and reactive oxygen species induction.
Wang YY; Chen YK; Hsu YL; Chiu WC; Tsai CH; Hu SC; Hsieh PW; Yuan SF
Head Neck; 2017 Jun; 39(6):1055-1064. PubMed ID: 28346709
[TBL] [Abstract][Full Text] [Related]
6. 3'-hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumorigenesis in colorectal cancer cells through ROS-mediated DNA damage and mitochondrial dysfunction.
Tsai CH; Hung AC; Chen YY; Chiu YW; Hsieh PW; Lee YC; Su YH; Chang PC; Hu SC; Yuan SF
Oncotarget; 2017 Mar; 8(11):18106-18117. PubMed ID: 28178649
[TBL] [Abstract][Full Text] [Related]
7. 3'-Hydroxy-4'-methoxy-β-methyl-β-nitrostyrene inhibits tumor growth through ROS generation and GSH depletion in lung cancer cells.
Tsai CH; Hsieh PW; Lee YC; Wang CH; Chiu WC; Lu CW; Wang YY; Hu SC; Cheng TL; Yuan SF
Life Sci; 2017 Mar; 172():19-26. PubMed ID: 28007499
[TBL] [Abstract][Full Text] [Related]
8. Icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways.
Gu ZF; Zhang ZT; Wang JY; Xu BB
Environ Toxicol Pharmacol; 2017 Sep; 54():7-13. PubMed ID: 28667862
[TBL] [Abstract][Full Text] [Related]
9. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
[TBL] [Abstract][Full Text] [Related]
10. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
11. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
12. MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS.
Huang L; Lin H; Chen Q; Yu L; Bai D
BMC Cancer; 2019 Nov; 19(1):1159. PubMed ID: 31783821
[TBL] [Abstract][Full Text] [Related]
13. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
[TBL] [Abstract][Full Text] [Related]
14. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
[TBL] [Abstract][Full Text] [Related]
15. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
[TBL] [Abstract][Full Text] [Related]
16. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
[TBL] [Abstract][Full Text] [Related]
17. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
[TBL] [Abstract][Full Text] [Related]
18. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.
Zheng YB; Xiao GC; Tong SL; Ding Y; Wang QS; Li SB; Hao ZN
World J Gastroenterol; 2015 Jun; 21(23):7197-207. PubMed ID: 26109806
[TBL] [Abstract][Full Text] [Related]
19. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
[TBL] [Abstract][Full Text] [Related]
20. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
